Key Points
- Ticagrelor (Brilinta) is an antiplatelet medication that prevents dangerous blood clots from forming inside heart arteries, particularly after a heart attack or coronary stent placement.
- It is almost always prescribed alongside low-dose aspirin, a combination known as dual antiplatelet therapy (DAPT) which provides stronger clot protection than either medicine alone.
- Unlike older antiplatelets like clopidogrel, ticagrelor works directly and more quickly, providing a more consistent and reliable effect.
- The most common side effect is mild breathlessness, particularly in the first few weeks. This is usually not dangerous but should be discussed with your doctor if it persists.
- Never stop ticagrelor suddenly without speaking to your cardiologist first. Stopping abruptly can significantly increase the risk of a serious clot forming, particularly around a stent.
If you have recently had a heart attack or had a stent placed in one of your coronary arteries, you may have been prescribed a medication called ticagrelor, commonly known by the brand name Brilinta. It is completely understandable to want to know why you are taking it, how it works, and what to expect.
This article will walk you through those questions in a clear and practical way. Understanding your medication is an important part of feeling confident about your recovery, and we are here to help with that.
What Is Ticagrelor and Why Has It Been Prescribed?
Ticagrelor is an antiplatelet medication. Its main role is to prevent blood clots from forming inside the arteries of the heart. Platelets are small cells in your blood that normally help stop bleeding by clumping together. While this is a vital function when you have a cut or injury, it becomes a problem when platelets clump inside a narrowed or freshly stented artery, where they can trigger a dangerous blockage.
Ticagrelor reduces platelet activity to lower this risk. It is most commonly prescribed after a heart attack, unstable angina, or a coronary procedure such as stent placement, all situations where the risk of a new clot forming is highest. Your treating team will typically start it during your hospital admission.
After a stent is placed, there is a critical period during which the body is healing and the stent is becoming incorporated into the artery wall. Ticagrelor is essential protection during this time, it significantly reduces the risk of a clot forming around the stent before that healing is complete.
Dual Antiplatelet Therapy, Why Two Medicines?
Ticagrelor is almost always prescribed alongside low-dose aspirin. This combination is called dual antiplatelet therapy or DAPT. The two medicines work through different pathways to block platelet activity, meaning together they provide significantly stronger protection than either one alone.
| Aspirin | Ticagrelor (Brilinta) | |
|---|---|---|
| How it works | Blocks thromboxane A2 pathway, reduces platelet activation | Blocks P2Y₁₂ receptor, prevents platelets from sticking together |
| Onset of action | Within 1 hour | Within 30–60 minutes, faster than clopidogrel |
| Dosing | 75–100mg once daily | 90mg twice daily (or 60mg twice daily long-term in some cases) |
| Reversibility | Irreversible, platelets affected for their lifetime | Reversible, platelet function recovers within 3–5 days of stopping |
| Why combined | Different mechanisms provide complementary, stronger clot protection together | |
Your cardiologist will advise how long to continue DAPT based on your individual circumstances, typically 6 to 12 months, though this varies depending on the type of stent used, your bleeding risk, and the nature of your heart condition.
How Does Ticagrelor Work?
Ticagrelor works by blocking a receptor on the surface of platelets called P2Y₁₂. This prevents platelets from becoming activated and clumping together.
Unlike older antiplatelet medicines like clopidogrel, which need to be converted into their active form by the liver before working, ticagrelor works directly. This means it acts more quickly and produces a more consistent, reliable antiplatelet effect, which is why it is generally preferred in the days and weeks immediately following a heart attack or stenting, when reliable protection matters most.
Another important difference is that ticagrelor’s effect on platelets is reversible. Once the medication is stopped, platelet function gradually returns to normal within three to five days. This can be important if surgery is needed, see below.
How to Take It
Ticagrelor is usually taken as 90mg twice daily once in the morning and once in the evening, approximately 12 hours apart. It is taken alongside a daily low-dose aspirin. After 12 months, some patients are transitioned to a lower dose of 60mg twice daily for longer-term maintenance, depending on their circumstances.
Take it at the same times each day to keep its effect steady. It can be taken with or without food. If you miss a dose, take it as soon as you remember, unless it is almost time for the next one, in which case skip the missed dose and continue your normal schedule. Do not double up.
If You Need Surgery or a Procedure
This is one of the most important practical considerations for anyone on ticagrelor. Because it reduces the blood’s ability to clot, it needs to be carefully managed around any surgical procedure, including dental surgery, colonoscopy, and elective operations.
In most cases, ticagrelor should be stopped 3 to 5 days before a planned procedure to allow platelet function to recover. However, this decision should never be made without discussing it with both your cardiologist and the surgical or procedural team. Stopping antiplatelet therapy around the time of a stent procedure carries its own risk, and the timing must be carefully balanced.
If you are ever told by another specialist to stop ticagrelor before a procedure, always loop in your cardiologist before doing so. This is a decision that requires coordination between your care teams.
Possible Side Effects
Most people tolerate ticagrelor well, but there are some side effects worth knowing about, particularly because some of them can be unexpected if you are not prepared.
Side Effects, What to Know
- Breathlessness or heavier breathing the most commonly reported side effect, particularly in the first few weeks. It is usually mild and not related to a heart or lung problem. The exact mechanism is not fully understood but it is thought to involve adenosine pathways in the body. For most people it eases over time. If it persists, worsens, or is accompanied by chest pain, speak to your doctor.
- Easy bruising more common than usual due to reduced platelet activity. This is expected and not dangerous in itself.
- Nosebleeds or bleeding gums mild bleeding from these sites is common. Apply gentle pressure and it should resolve.
- Longer bleeding from cuts small wounds may take longer to stop bleeding. Apply firm pressure for longer than usual.
- Headache or dizziness occasionally reported, usually mild.
- Slow heart rate (bradycardia) a less common side effect, more relevant in people with existing rhythm issues.
- Serious bleeding rare but important to recognise. Seek urgent medical attention if you notice: vomiting blood, blood in the stool or very dark tarry stools, coughing up blood, or signs of internal bleeding such as sudden severe abdominal pain.
When Should You Seek Help Urgently?
Contact Your Doctor or Go to Emergency If You Notice:
- Vomiting blood or material that looks like coffee grounds
- Black, tarry, or blood-stained stools
- Coughing up blood
- A cut that will not stop bleeding after prolonged firm pressure
- Sudden severe chest pain, especially after stopping ticagrelor
- Signs of stroke, sudden face drooping, arm weakness, or speech difficulty
Is Ticagrelor Suitable for Everyone?
Ticagrelor is not appropriate for everyone. Your cardiologist will have carefully considered your individual circumstances before prescribing it. It is generally not recommended for people with:
| Situation | Why It May Be a Concern |
|---|---|
| History of significant bleeding (e.g. stomach ulcer) | Increased bleeding risk may outweigh clot-prevention benefit |
| Prior haemorrhagic stroke (bleeding in the brain) | Antiplatelet therapy significantly increases risk of recurrence |
| Severe liver disease | Affects how the medication is processed and cleared |
| Taking warfarin or DOACs (blood thinners) | Triple therapy significantly raises bleeding risk, requires specialist guidance |
| Severe asthma or COPD | Breathlessness side effect may be more problematic |
| Certain interacting medications | Strong antibiotics, antifungals, and seizure medicines can affect ticagrelor levels |
If any of these apply to you, it does not necessarily mean ticagrelor is off the table, but it does mean the decision requires more careful discussion with your cardiologist, who may consider an alternative such as clopidogrel or a different DAPT regimen.
Conclusion
Ticagrelor is a key part of modern heart care, particularly after a heart attack or stent procedure. It significantly reduces the risk of future events by protecting the arteries from dangerous clot formation during a critical period of healing.
Like any powerful medicine, it comes with side effects and considerations, but with proper guidance, regular follow-up, and an understanding of what to expect, most people take it safely and effectively.
If you are ever uncertain about your medication, notice concerning symptoms, or are facing another procedure, do not hesitate to contact your cardiologist. You are not alone in this, and understanding your treatment is an important step in feeling confident about your heart health journey.
